Health disparities

Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors

Ferri GM, Martinez CB, Acevedo J, …, Szalat RE, Sloan JM

Breast Cancer Research and Treatment215(1)DOI: Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitorsPubMed: Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors

Implementing geriatric assessments using the practical geriatric assessment in older adults being evaluated for cellular therapies at a safety-net hospital

Abdallah M, Fogale A, Halpin M, Szalat R, Fantasia K

Journal of Geriatric Oncology16(8):102667DOI: Implementing geriatric assessments using the practical geriatric assessment in older adults being evaluated for cellular therapies at a safety-net hospital

Neighborhood disadvantage and multiple myeloma incidence in the Black Women’s Health Study

Holder EX, Szalat R, Palmer JR, Bertrand KA

International Journal of Epidemiology54(6)DOI: Neighborhood disadvantage and multiple myeloma incidence in the Black Women’s Health StudyPubMed: Neighborhood disadvantage and multiple myeloma incidence in the Black Women’s Health Study

Body size and risk of multiple myeloma in the Black Women’s Health Study

Kataria Y, Pillalamarri BN, Zirpoli G, Szalat R, Palmer JR, Bertrand KA

British Journal of Cancer130(5):830-835DOI: Body size and risk of multiple myeloma in the Black Women’s Health StudyPubMed: Body size and risk of multiple myeloma in the Black Women’s Health Study

Deciphering racial disparities in multiple myeloma outcomes

Bertrand KA, Szalat R

Blood Advances8(1):234-235DOI: Deciphering racial disparities in multiple myeloma outcomesPubMed: Deciphering racial disparities in multiple myeloma outcomes

Febrile neutropenia in patients with Duffy-null–associated neutrophil counts and multiple myeloma or AL amyloidosis

Abdallah M, Arters F, Patel J, …, Szalat R

Blood Advances8(23):5935-5938DOI: Febrile neutropenia in patients with Duffy-null–associated neutrophil counts and multiple myeloma or AL amyloidosisPubMed: Febrile neutropenia in patients with Duffy-null–associated neutrophil counts and multiple myeloma or AL amyloidosis

Prevalence of monoclonal gammopathy of undetermined significance in US black women

Bertrand KA, Zirpoli G, Pillalamarri BN, Szalat R, Palmer JR, Kataria Y

American Journal of Hematology97(9)DOI: Prevalence of monoclonal gammopathy of undetermined significance in US black womenPubMed: Prevalence of monoclonal gammopathy of undetermined significance in US black women

Lack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA study

Fillmore NR, Cirstea D, Munjuluri A, …, Szalat RE, Munshi NC

Blood Advances5(18):3511-3514DOI: Lack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA studyPubMed: Lack of differential impact of del17p on survival in African Americans compared with White patients with multiple myeloma: a VA study

Effect of duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors

Ferri G, Beiner Martinez C, Acevedo J, Bhatt S, Verma K, Abdallah M, Szalat R, Sloan JM

Blood146(Supplement 1):6170-6170DOI: Effect of duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors

Disparities in Monoclonal Immunoglobulin-Associated Disorders in a Large and Diverse Cohort from a US Tertiary Safety-Net Center

Aijaz A, Szalat RE

Blood144(Supplement 1):6899-6899DOI: Disparities in Monoclonal Immunoglobulin-Associated Disorders in a Large and Diverse Cohort from a US Tertiary Safety-Net Center

Epidemiological Characteristics and Clinical Outcomes of Patients with Monoclonal Gammopathy of Renal Significance (MGRS) Diagnosed in a Large Safety-Net Hospital in the US

Granina E, Henderson J, Bertrand KA, Sanchorawala V, Szalat RE

Blood144(Supplement 1):4680-4680DOI: Epidemiological Characteristics and Clinical Outcomes of Patients with Monoclonal Gammopathy of Renal Significance (MGRS) Diagnosed in a Large Safety-Net Hospital in the US

Epidemiology and clinical characteristics of patients with monoclonal gammopathy of renal significance (MGRS) in a diverse population

Granina E, Henderson J, Bertrand K, Sanchorawala V, Szalat R

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS31:S135-S135

When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias

Abdallah M, Arters F, Patel J, …, Szalat RE

Blood142(Supplement 1):7432-7432DOI: When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias

Whole Genome Sequencing of Unique Paired SMM/MGUS Progressing to MM Samples Reveals a Genomic Landscape with Diverse Evolutionary Pattern

Bolli N, Maura F, Minvielle S, …, Szalat R, …, Munshi N

Blood128(22):2088-2088DOI: Whole Genome Sequencing of Unique Paired SMM/MGUS Progressing to MM Samples Reveals a Genomic Landscape with Diverse Evolutionary Pattern